Suppr超能文献

胆钙化醇水平及其对新冠肺炎患者的影响。

Cholecalciferol level and its impact on COVID-19 patients.

作者信息

Saeed Mohammed Abdel Monem, Mohamed Alaa Hussein, Owaynat Ahmed Hassan

机构信息

Critical Care Medicine Department, Faculty of Medicine Helwan University, Helwan, Egypt.

Clinical Pharmacy Department, Helwan University Hospitals, Helwan, Egypt.

出版信息

Egypt J Intern Med. 2022;34(1):23. doi: 10.1186/s43162-022-00116-w. Epub 2022 Feb 21.

Abstract

BACKGROUND

Cholecalciferol is an important nutrient and essential to build body, maintain strong bones, and improves immunity.The main source for vitamin D is the body's skin which absorbs the sun's ultraviolet rays and convert them into vitamin D; at the same time, deficiency can occur or people may not get enough supplementation; this occurs mainly in old age, not taking healthy food, or have darker skin, and this deficient cases can raise the risk of severe COVID-19 if infected.Vitamin D boosts immunity and decreases inflammation. Poorer outcome of corona virus-disease (COVID-19) has been suggested to be due to vitamin D deficiency.We suggested to find the effect of cholecalciferol levels 25-hydroxy vitamin D (25 OHD) on the severity and mortality in patients suffering from COVID-19.

METHODS

Our study is a prospective following of 414 patients admitted in Helwan University Hospitals in the period of June 2020 till October 2021 for severely symptomatic. COVID-19 patients with median of age 54.55 ± 14.27, with a definite range of APACHE II score ranging from 15 to 19 where we measured vitamin D level (cholecalciferol level), correlating the assay level to the inflammatory cytokine storm markers on admission, on the fifth day and after 10 days also the level of vitamin D was correlated to the length of stay mechanical ventilation days and mortality.

RESULTS

Lower level of vitamin D on admission was strongly evident in patients with severely symptomatic and in mortality of COVID-19 patients 58.25 ± 24.59 nmol/L when compared with patients who survived 103.97 ± 36.14 nmol/L with value < 0.001.Also, when correlating the initial level of vitamin D on admission with the level of the inflammatory cytokine storm markers on admission, on fifth day from admission and on the tenth day, it shows a strong inverse correlation between vitamin D level on admission and ferritin level on fifth day ρ-0.739 value < 0.001 also on the tenth day ρ-0.885, value < 0.001, in comparing also with D-dimer on fifth day ρ-0.858, value < 0.001 also showing a strong inverse correlation with a highly significant value this also evident on the D-dimer level on the tenth day ρ-0.889 with value < 0.001, CRP at fifth and tenth day ρ-0.868, value < 0.001, ρ-0.891, value < 0.001 respectively also in correlating the LDH level on the fifth and tenth day with the initial level of vitamin D it shows a strong inverse correlation with a highly significant value. ρ-0.887, value < 0.001, ρ-0.878, value < 0.001 respectively, in the fifth and tenth day. Neutrophil to lymphocyte ratio was strongly, inversely correlated to the vitamin D level (cholecalciferol) on admission with ρ-0.753, < 0.001, ρ-0.882, < 0.001 respectively. Also, chest computed tomography in the fifth and tenth day of admission showed a very strong inverse correlation with vitamin D level and a highly significant statistical difference ρ-0.655, value < 0.001 respectively.Length of stay and mechanical ventilation days were also strongly inversely correlated to the cholecalciferol level ρ-0.795, < 0.001, ρ- 0.879, < 0.001 ROC curve of vitamin D to predict mortality (RR 0.865, 95% CI 0.828-0.896, < 0.001, with cut off-value for vit. D < 60 nmol/L, regardless of other factors like age, gender, and presence of other co-morbidities.

CONCLUSION

Low level of cholecalciferol was strongly inversely correlated with cytokine storm markers and independent predictor of severity and mortality in COVID-19 patients.

摘要

背景

胆钙化醇是一种重要营养素,对身体发育、维持骨骼强健及提高免疫力至关重要。维生素D的主要来源是人体皮肤,其吸收太阳紫外线并将其转化为维生素D;同时,可能会出现维生素D缺乏或人们补充不足的情况;这主要发生在老年人、未摄入健康食物或皮肤较黑的人群中,而这种缺乏情况若感染新冠病毒,会增加患重症COVID-19的风险。维生素D可增强免疫力并减轻炎症。有研究表明,冠状病毒病(COVID-19)预后较差可能与维生素D缺乏有关。我们建议研究25-羟基维生素D(25 OHD)水平的胆钙化醇对COVID-19患者病情严重程度和死亡率的影响。

方法

我们的研究是对2020年6月至2021年10月期间在赫尔万大学医院收治的414例有严重症状的患者进行前瞻性随访。这些COVID-19患者的年龄中位数为54.55±14.27岁,急性生理与慢性健康状况评分系统(APACHE II)评分为15至19分,我们测量了维生素D水平(胆钙化醇水平),将检测水平与入院时、第5天和10天后的炎症细胞因子风暴标志物进行关联,同时将维生素D水平与机械通气天数和住院时间以及死亡率进行关联。

结果

与存活患者的103.97±36.14 nmol/L相比,有严重症状的COVID-19患者入院时维生素D水平较低,为58.25±24.59 nmol/L,P值<0.001。此外,将入院时维生素D的初始水平与入院时、入院第5天和第10天的炎症细胞因子风暴标志物水平进行关联时,结果显示入院时维生素D水平与第5天铁蛋白水平呈强烈负相关,ρ=-0.739,P值<0.001,第10天时ρ=-0.885,P值<0.001;与第5天D-二聚体相比,ρ=-0.858,P值<0.001,也显示出强烈负相关且具有高度显著性P值,第10天D-二聚体水平ρ=-0.889,P值<0.001;第5天和第10天的C反应蛋白(CRP)分别为ρ=-0.868,P值<0.001,ρ=-0.891,P值<0.001;将第第5天和第10天的乳酸脱氢酶(LDH)水平与维生素D的初始水平进行关联时,也显示出强烈负相关且具有高度显著性P值,第5天和第10天分别为ρ=-0.887,P值<0.001,ρ=-0.878,P值<0.001。中性粒细胞与淋巴细胞比值与入院时维生素D水平(胆钙化醇)呈强烈负相关,分别为ρ=-0.753,P<0.001,ρ=-0.882,P<0.001。此外,入院第5天和第10天的胸部计算机断层扫描显示与维生素D水平呈非常强烈的负相关且具有高度显著的统计学差异,分别为ρ=-0.655,P值<0.001。住院时间和机械通气天数也与胆钙化醇水平呈强烈负相关,ρ=-0.795,P<0.001,ρ=-0.879,P<0.001。维生素D预测死亡率的ROC曲线(风险比0.865,95%置信区间0.828-0.896,P<0.001),维生素D临界值<60 nmol/L,不受年龄、性别和其他合并症等其他因素影响。

结论

胆钙化醇水平低与细胞因子风暴标志物呈强烈负相关,是COVID-19患者病情严重程度和死亡率的独立预测指标。

相似文献

1
Cholecalciferol level and its impact on COVID-19 patients.胆钙化醇水平及其对新冠肺炎患者的影响。
Egypt J Intern Med. 2022;34(1):23. doi: 10.1186/s43162-022-00116-w. Epub 2022 Feb 21.
7
Vitamin D levels in Swiss breast cancer survivors.瑞士乳腺癌幸存者的维生素D水平
Swiss Med Wkly. 2018 Jan 16;148:w14576. doi: 10.4414/smw.2018.14576. eCollection 2018.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验